English soccer champions Manchester City FC have engaged Japanese conglomerate Sony Corporation in a global partnership to develop new digital fan experiences, mainly on metaverse.
Both parties would create a global online fan community where the team and its followers interact within the metaverse, to be designed as a virtual recreation of the club’s Etihad Stadium.
Manchester City will also leverage Sony’s technologies and various digital fan experiences in music and the wider entertainment industries to develop new forms of digital content.
According to the team, the new experiences will be at the cutting-edge of global sport’.
The club will be Sony’s first sports partner in the space.
Nuria Tarre, chief marketing and fan experience officer at City Football Group (CFG), says the partnership with Sony puts the team at the development stage of creating immersive digital fan experiences never seen before in football.


Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Trump-Xi Summit 2026: U.S.-China Trade War Tensions and Tariff Talks
Trump Set to Announce Washington D.C. as Host of 2027 NFL Draft
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Makemation: a Nollywood movie that shows AI in action in Africa
Apple Turns 50: From Garage Startup to AI Crossroads
Oil Prices Surge as U.S.-Iran Conflict Threatens Global Supply
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



